Biotech · Private company · Ann Arbor, MI, US
Innovative Biotherapies, Inc.
Track this companyFree. Adds Innovative Biotherapies, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards3
- Cell Directed Immunomodulation Therapy as a Bridge to Left Ventricular Device Implantation in Chronic Heart Failure PatientsFiscal year 2026 · $797.4KNIH RePORTER 5R44HL170779-03 · fetched Nov 12, 2026
- Cell Directed Immunomodulation Therapy as a Bridge to Left Ventricular Device Implantation in Chronic Heart Failure PatientsFiscal year 2025 · $1.5MNIH RePORTER 5R44HL170779-02 · fetched Nov 12, 2026
- Cell Directed Immunomodulation Therapy as a Bridge to Left Ventricular Device Implantation in Chronic Heart Failure PatientsFiscal year 2024 · $1.3MNIH RePORTER 1R44HL170779-01A1 · fetched Nov 12, 2026